Welcome to our dedicated page for Chemours news (Ticker: CC), a resource for investors and traders seeking the latest updates and insights on Chemours stock.
The Chemours Company reports developments for a global industrial and specialty chemicals business organized around Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. News commonly covers earnings releases, quarterly dividends, debt financing, and segment demand for products sold under brands including Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™.
Company updates also address refrigerants and thermal-management applications, TiO2 pigment pricing and volume trends, advanced fluoropolymers for semiconductor and electronics markets, and collaborations tied to high-density IT cooling and other specialty-chemistry uses.
Chemours (NYSE: CC) announced a quarterly cash dividend of $0.0875 per share for the first quarter of 2026. The dividend is payable on March 13, 2026 to holders of record at the close of business on February 27, 2026.
This action signals a current cash return to shareholders for Q1 2026.
Chemours (NYSE: CC) expects to release its fourth quarter 2025 financial results after market on Thursday, February 19, 2026 and to host a public webcast conference call at 8:00 a.m. ET on Friday, February 20, 2026.
Investors can access the live webcast, accompanying slides, and a replay via the Events and Presentations section of Chemours' Investor Relations website at investors.chemours.com.
Chemours (NYSE: CC) signed definitive agreements on Jan. 15, 2026 to sell the remaining land at its former titanium dioxide manufacturing site in Kuan Yin, Taiwan to an ownership group including Century Wind Power, Century Iron & Steel Industrial, and Century Huaxin Wind Energy.
The land sale is expected to generate approximately $360 million in gross cash proceeds, prior to customary taxes and fees, and is expected to substantially close by mid‑year 2026 subject to local regulatory approval, inclusive of environmental conditions. The company said it will apply the cash proceeds to reduce its debt obligations.
Chemours (NYSE: CC) appointed Michael Foley as President of Titanium Technologies, effective February 2026, and announced the departure of Damián Gumpel.
The company said CEO Denise Dignam will provide leadership support during the transition. Foley previously led a $1 billion Formulated Specialties portfolio at Momentive, overseeing 8 manufacturing sites and 2,000 employees, and has experience in Lean and Six Sigma. Chemours said the move supports its TT value-based strategy and ongoing execution of the Pathway to Thrive plan for titanium dioxide (TiO2) markets.
Chemours (NYSE: CC) reported Q3 2025 net sales of $1.5B (flat YoY) and net income of $60M or $0.40 per diluted share versus a loss year-ago. Adjusted EBITDA was $195M versus $202M a year earlier. Key segment drivers included TSS Opteon™ revenue up 80% YoY and TSS Adjusted EBITDA of $194M (+40% YoY).
TT Adjusted EBITDA fell to $25M (down 68% YoY) and APM Adjusted EBITDA fell to $14M with outage-related costs ~$20M. Net debt was $3.6B (gross debt $4.2B) and net leverage ~4.6x. Q4 2025 guidance: consolidated Adjusted EBITDA $130–160M and sequential net sales down 10–15%.
Chemours (NYSE: CC) declared a quarterly cash dividend of $0.0875 per share for Q4 2025.
The dividend will be paid on December 15, 2025 to holders of record at the close of business on November 14, 2025.
Chemours (NYSE: CC) expects to release its third quarter 2025 financial results after market close on Thursday, November 6, 2025. Management plans a public conference call and webcast at 8:00 a.m. Eastern Time on Friday, November 7, 2025 to discuss results.
Prior to the call, prepared financial remarks will be posted in the Events and Presentations section of the Investor Relations website at investors.chemours.com. A live webcast link, accompanying slides, and a replay will be available on the same site.
Chemours (NYSE:CC) has announced key Board leadership changes effective September 2, 2025. Mary Cranston, a director since 2015, has been appointed as Chair of the Board, while Alister Cowan has been named Lead Independent Director. These appointments follow Dawn Farrell's departure to lead Canada's Major Projects Office.
Cranston, who led Chemours' Board refresh, brings extensive governance experience from serving on boards of global companies including Visa, McAfee, and TPG. Cowan, appointed to the Board in 2023, brings over 30 years of financial executive experience and chairs the Audit, Risk, and Finance Committee. The new leadership structure will focus on executing Chemours' Pathway to Thrive strategy.
Chemours (NYSE: CC) has released its 2024 Sustainability Report, highlighting significant progress towards its Corporate Responsibility Commitment (CRC) goals. The company achieved a 76% reduction in fluorinated organic chemical emissions since 2018, a 52% reduction in Scope 1 and 2 greenhouse gas emissions, and reached its 2030 Sustainable Offerings goal six years early with 50% of revenue now coming from products contributing to UN Sustainable Development Goals.
Under new CEO Denise Dignam's leadership, Chemours introduced sustainable innovations including liquid cooling solutions for data centers that can reduce cooling energy use by up to 90% and advanced EV battery binders that can reduce manufacturing footprint by 75% and energy consumption by approximately 47%.
Chemours (NYSE: CC) has announced strategic agreements with SRF Limited to strengthen its global supply chain for fluoropolymers and fluoroelastomers by 2026. The collaboration leverages SRF's manufacturing capabilities in India to produce essential materials used in semiconductor, automotive, aerospace, chemical processing, and oil and gas industries.
The partnership aligns with Chemours' Pathway to Thrive strategy, focusing on higher-value applications while requiring no upfront capital investment. The agreement will enhance Chemours' operational flexibility and ensure reliable product supply for customers worldwide by combining SRF's manufacturing excellence with Chemours' product technology and quality standards.